Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 20.18% is in line with its 5-year average of 19.14%, near the high end of its 5-year range (6.55%–21.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.20% below its 12-month average of 20.23%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 20.18%.
RETURN ON INVESTED CAPITAL (ROIC)
20.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
20.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
19.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
19.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
14.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.20%
CURRENT VS 3Y AVG
+1.45%
CURRENT VS 5Y AVG
+5.48%
CURRENT VS 10Y AVG
+41.57%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.78%
median of 596 covered companies
CURRENT VS SECTOR MEDIAN
+158.03%
vs the sector median at left
IRadimed Corporation
Market Cap
$1.09B
Return on Invested Capital (ROIC)
20.18%
TTM Avg
20.23%
3Y Avg
19.90%
5Y Avg
19.14%
Market Cap
$1.09B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
9.95%
3Y Avg
11.37%
5Y Avg
9.31%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
Market Cap
$1.05B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$1.05B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-3.44%
3Y Avg
-10.34%
5Y Avg
-8.68%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
-52.44%
TTM Avg
-96.82%
3Y Avg
-100.85%
5Y Avg
-77.97%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.19B
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-57.11%
3Y Avg
-57.11%
5Y Avg
-57.11%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IRadimed Corporation (IRMD) | $1.09B | 20.18% | 20.23% | 19.90% | 19.14% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -42.98% | -26.82% | -23.95% | -23.95% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.11B | 5.93% | 9.95% | 11.37% | 9.31% |
| Harrow Health, Inc. (HROW)vs › | $1.11B | 1.81% | 7.83% | 4.30% | 3.30% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.32% | -21.18% | -91.27% | -61.58% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.05B | -6.33% | -3.44% | -10.34% | -8.68% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | -52.44% | -96.82% | -100.85% | -77.97% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -67.73% | -67.73% | -67.73% | -67.73% |
| Kardigan, Inc. (KARD)vs › | $1.19B | -57.11% | -57.11% | -57.11% | -57.11% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.86% | 2.66% | 2.26% | 2.26% |
ROIC
20.2%
ROE
22.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 20.18% |
| 2026-03-31 | 21.38% |
| 2025-12-31 | 21.02% |
| 2025-09-30 | 19.19% |
| 2025-06-30 | 19.35% |
| 2025-03-31 | 19.24% |
| 2024-12-31 | 19.38% |
| 2024-09-30 | 19.52% |
| 2024-06-30 | 20.53% |
| 2024-03-31 | 20.47% |
| 2023-12-31 | 20.90% |
| 2023-09-30 | 18.92% |
| 2023-06-30 | 18.57% |
| 2023-03-31 | 18.92% |
| 2022-12-31 | 16.10% |
| 2022-09-30 | 17.52% |
| 2022-06-30 | 17.52% |
| 2022-03-31 | 15.75% |
| 2021-12-31 | 12.24% |
| 2021-09-30 | 8.39% |
| 2021-06-30 | 6.55% |
| 2021-03-31 | 0.42% |
| 2020-12-31 | -1.14% |
| 2020-09-30 | 1.27% |
| 2020-06-30 | 4.04% |
| 2020-03-31 | 12.40% |
| 2019-12-31 | 14.21% |
| 2019-09-30 | 13.62% |
| 2019-06-30 | 13.72% |
| 2019-03-31 | 13.01% |
| 2018-12-31 | 13.72% |
| 2018-09-30 | 11.07% |
| 2018-06-30 | 6.52% |
| 2018-03-31 | 4.14% |
| 2017-12-31 | 2.02% |
| 2017-09-30 | 4.07% |
| 2017-06-30 | 8.39% |
| 2017-03-31 | 13.85% |
| 2016-12-31 | 21.45% |
| 2016-09-30 | 26.44% |
| 2016-06-30 | 29.71% |
| 2016-03-31 | 27.66% |
| 2015-12-31 | 23.03% |
| 2015-09-30 | 18.78% |
| 2015-06-30 | 14.85% |
| 2015-03-31 | 13.05% |
| 2014-12-31 | 9.90% |
| 2014-09-30 | 11.21% |
| 2014-06-30 | 30.68% |
| 2014-03-31 | 29.28% |
| 2013-12-31 | 35.00% |
